Evogene Ltd.
EVGN
$0.97
-$0.0255-2.56%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 106.47% | 22.84% | -120.18% | 39.12% | 39.12% |
| Total Depreciation and Amortization | -10.56% | -5.26% | 3.43% | 2.48% | 2.48% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -939.69% | -40.31% | -114.50% | 180.79% | 180.79% |
| Change in Net Operating Assets | -195.25% | -178.19% | 59.89% | -204.19% | -204.19% |
| Cash from Operations | 12.12% | -7.15% | -162.52% | 38.82% | 38.82% |
| Capital Expenditure | -274.42% | 75.00% | 56.78% | 4.00% | 4.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,916.00% | 141.68% | -101.61% | 1,801.48% | 1,801.48% |
| Cash from Investing | 1,594.54% | 140.63% | -31.10% | 16,663.64% | 16,663.64% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 2.83% | -11.59% | 51.49% | -- | -- |
| Issuance of Common Stock | 1,335.56% | 22.06% | 114.29% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -100.03% | -66.67% | -100.58% | -100.58% |
| Cash from Financing | 399.32% | -101.45% | 58.71% | -23.30% | -23.30% |
| Foreign Exchange rate Adjustments | -107.07% | 84.30% | -45.00% | 71.13% | 71.13% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 160.74% | 12.14% | -127.74% | 137.15% | 137.15% |